BIOMERIEUX

bioMérieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company offers microbiology technology that involves culturing biological samples; and immunoassays technology based on antigen-antibody reaction, detects and measures infectious agents, such as bacteria, viruses, and parasites, as well as measures the specific biomarkers of various pathologies, such as metabolic, hormonal, infectious, etc. Show More...

  • Website http://www.biomerieux.com
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Last Quote 118.10 EUR
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share EUR 1.34 1.34 1.14 1.39 1.14 0.93 4.54 2.01 2.17 2.3 2.3
    Dividends EUR 0.31 0.33 0.33 0.33 0.33 0.33 0.33 0.33 0.34 0.35 0.35
    Payout Ratio % * 22.8 24.0 28.7 28.7 28.9 27.4 28.9 20.2 57.6 15.8 15.2
    Shares Mil 118.0 118.0 118.0 118.0 118.0 118.0 118.0 118.0 118.0 119.0 119.0
    Book Value Per Share * EUR 8.21 8.31 10.09 10.12 10.7 12.11 12.72 13.86 15.61 17.46 18.72
    Free Cash Flow Per Share * EUR 0.64 0.72 1.11 0.89 1.0 0.95 0.9 1.04 1.39 1.45
    Return on Assets % 11.72 9.85 7.48 8.15 5.65 4.13 6.17 7.91 8.04 7.61 7.61
    Financial Leverage (Average) 1.49 1.61 1.54 1.74 1.87 1.86 1.87 1.72 1.76 1.71 1.71
    Return on Equity % 17.9 15.31 11.74 13.39 10.21 7.69 11.5 14.19 14.0 13.2 13.2
    Return on Invested Capital % 17.2 14.09 10.49 11.11 8.43 6.64 9.64 11.74 11.54 11.0 11.0
    Interest Coverage 76.44 55.05 48.6 63.33 13.82 11.2 16.15 19.14 20.0 16.71 16.71
    Current Ratio 1.73 1.38 1.67 2.41 1.66 1.6 1.55 1.97 1.71 1.23 1.23
    Quick Ratio 1.28 0.95 1.03 1.75 0.98 0.94 0.92 1.25 1.07 0.75 0.75
    Debt/Equity 0.010 0.010 0.010 0.24 0.22 0.21 0.23 0.23 0.23 0.07 0.07